Recurrent Adult Diffuse Large Cell Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
2022-02-28
Feb 28, 2022
J
Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
Active, not recruiting
  • Prolymphocytic Leukemia
  • +4 more
  • Columbus, Ohio
  • +1 more
2022-02-24
Feb 24, 2022
C
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma
Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +23 more
  • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
2022-02-16
Feb 16, 2022
M
Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Active, not recruiting
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
2022-02-03
Feb 3, 2022
S
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +67 more
  • Fludarabine phosphate
  • +8 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2021-08-31
Aug 31, 2021
F
High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma - 2020
Terminated
Has Results
  • Post-Transplant Lymphoproliferative Disorder
  • +6 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-07-16
Jul 16, 2021
B
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma - 2015
Completed
Has Results
  • Adult Grade III Lymphomatoid Granulomatosis
  • +88 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
2021-04-14
Apr 14, 2021
R
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors - 2018
Completed
Has Results
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +58 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2021-03-23
Mar 23, 2021
F
Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies - 2018
Terminated
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +32 more
  • indium In 111 anti-CD45 monoclonal antibody BC8
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
2021-03-07
Mar 7, 2021
K
Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
Active, not recruiting
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +9 more
  • BTK inhibitor PCI-32765
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
2021-02-20
Feb 20, 2021
F
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Completed
  • Hematopoietic/Lymphoid Cancer
  • +135 more
  • beclomethasone dipropionate
  • +4 more
  • Hackensack, New Jersey
  • +1 more
2021-02-01
Feb 1, 2021
N
Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma - 2015
Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Akt inhibitor MK2206
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
2020-10-14
Oct 14, 2020
M
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma - 2020
Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +18 more
  • Scottsdale, Arizona
  • +1 more
2020-09-28
Sep 28, 2020
C
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20 - 2020
Completed
  • Hematopoietic/Lymphoid Cancer
  • +22 more
  • anti-CD19/20-CAR vector-transduced T cells
  • Beijing, Beijing, China
    Biotherapeutic Department and Pediatrics Department of Chinese P
2020-08-31
Aug 31, 2020
M
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma - 2019
Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +27 more
  • Scottsdale, Arizona
  • +2 more
2020-03-02
Mar 2, 2020
F
Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies - 2009
Completed
Has Results
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +99 more
  • alemtuzumab
  • +6 more
  • Denver, Colorado
  • +6 more
2020-01-15
Jan 15, 2020
F
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer - 2018
Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +173 more
  • fludarabine phosphate
  • +6 more
  • Salt Lake City, Utah
  • +4 more
2020-01-17
Jan 17, 2020
F
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
Completed
  • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
  • +76 more
  • fludarabine phosphate
  • +6 more
  • Tucson, Arizona
  • +10 more
2020-01-17
Jan 17, 2020
F
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer
Completed
  • Acute Undifferentiated Leukemia
  • +63 more
  • total-body irradiation
  • +7 more
  • Seattle, Washington
  • +1 more
2020-01-17
Jan 17, 2020
F
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +134 more
  • fludarabine phosphate
  • +6 more
  • Stanford, California
  • +9 more
2020-01-15
Jan 15, 2020
F
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma - 2002
Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Duarte, California
  • +4 more
2019-12-24
Dec 24, 2019
N
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors - 2015
Completed
Has Results
  • Adult B Acute Lymphoblastic Leukemia
  • +37 more
  • Bendamustine Hydrochloride
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2019-11-22
Nov 22, 2019
R
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders - 2019
Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +99 more
  • fludarabine phosphate
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2019-10-30
Oct 30, 2019
F
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer - 2015
Completed
Has Results
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +115 more
  • Fludarabine Phosphate
  • +6 more
  • Denver, Colorado
  • +10 more
2019-10-29
Oct 29, 2019
R
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies - 2019
Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +77 more
  • fludarabine phosphate
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2019-09-16
Sep 16, 2019